Biogen marked the groundbreaking for its 16-story Kendall Square headquarters in Cambridge, Massachusetts, anticipating completion by 2028 as it celebrates its 50th anniversary. CEO Christopher Viehbacher highlighted the innovation ecosystem surrounding Biogen, including advancements in diseases like Alzheimer’s and cancer. Despite industry headwinds and market uncertainties, the facility represents a major investment in biotech infrastructure and a commitment to future discovery and therapeutic development.